| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 8, 601-608, Copyright © 1994 by The Federation of American Societies for Experimental Biology
REVIEWS |
JM LaSalle and DA Hafler
Laboratory of Molecular Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115.
T cell clonal anergy is a proposed mechanism of immunologic self tolerance in which T cells become functionally inactivated after previous stimulation. MHC class II-restricted antigen presentation by different cell types has been speculated to have a role in determining activation vs. anergy in responding T cells. Human T cells express MHC class II after activation and have been shown to present high concentrations of degraded peptide antigen to autologous T cells resulting in clonal anergy. In contrast to low antigen dose T cell clonal anergy, which occurs in the absence of costimulation, T cell anergy induced by human T cell presentation of antigen results in both primary proliferation and secondary unresponsiveness to high-dose antigenic stimulation. Although clonal anergy was previously thought to prevent autoreactive T cells from ever responding to self antigen presented without costimulation, we postulate that T cell presentation of antigen represents a "fail-safe" mechanism of immunologic self tolerance that would anergize clonally expanded autoreactive T cells when they are surrounded by a high extracellular concentration of degraded self antigen.
This article has been cited by other articles:
|
|
 |
|
  M. D. Mannie and M. R. Walker Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders J. Leukoc. Biol., August 1, 2001; 70(2): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Creus, K. Van Beneden, T. Taghon, F. Stolz, V. Debacker, J. Plum, and G. Leclercq Langerhans Cells That Have Matured In Vivo in the Absence of T Cells Are Fully Capable of Inducing a Helper CD4 as Well as a Cytotoxic CD8 Response J. Immunol., July 15, 2000; 165(2): 645 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kimura, M. Yamashita, M. Kubo, M. Iwashima, C. Shimizu, K. Tokoyoda, J. Chiba, M. Taniguchi, M. Katsumata, and T. Nakayama Impaired Ca/calcineurin pathway in in vivo anergized CD4 T cells Int. Immunol., June 1, 2000; 12(6): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ribas, L. H. Butterfield, and J. S. Economou Genetic Immunotherapy for Cancer Oncologist, April 1, 2000; 5(2): 87 - 98. [Abstract] [Full Text]
|
|
|
|
|
|
O. Utting, S.-J. Teh, and H.-S. Teh A Population of In Vivo Anergized T Cells with a Lower Activation Threshold for the Induction of CD25 Exhibit Differential Requirements in Mobilization of Intracellular Calcium and Mitogen-Activated Protein Kinase Activation J. Immunol., March 15, 2000; 164(6): 2881 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Patel, P. Y. Arnold, G. A. White, J. P. Nardella, and M. D. Mannie Class II MHC/Peptide Complexes Are Released from APC and Are Acquired by T Cell Responders During Specific Antigen Recognition J. Immunol., November 15, 1999; 163(10): 5201 - 5210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. H. Wong, D. D. Dudley, N. H. Afdhal, J. Dienstag, C. M. Rice, L. Wang, M. Houghton, B. D. Walker, and M. J. Koziel Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection J. Immunol., February 1, 1998; 160(3): 1479 - 1488. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
